Difference between revisions of "European Medicines Agency"
(New page: ==Background== The European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promot...) |
(→People) |
||
| Line 15: | Line 15: | ||
==People== | ==People== | ||
| + | |||
| + | '''Management Board (MB)''' | ||
| + | |||
| + | According to the [[EMEA]]'s website, the MB is an integral governance body of the [[European Medicines Agency]] (EMEA). The Board has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance. | ||
| + | |||
| + | Individual members of the Management Board are appointed on the basis of their relevant expertise in management and, if appropriate, experience in the field of medicinal products for human or veterinary use, in such a way as to guarantee the highest levels of specialist qualifications, a broad spectrum of relevant expertise, and the broadest possible geographical spread within the European Union. | ||
| + | |||
| + | The Management Board has 35 members: | ||
| + | |||
| + | * 1 representative of each of the 27 Member States | ||
| + | * 2 representatives of the European Commission | ||
| + | * 2 representatives of the European Parliament | ||
| + | * 2 representatives of patients’ organisations | ||
| + | * 1 representative of doctors’ organisations | ||
| + | * 1 representative of veterinarians’ organisations | ||
| + | |||
| + | In 2009, the MB consists of: | ||
| + | |||
| + | * '''Chair''' | ||
| + | |||
| + | [[Pat O'Mahony]] | ||
| + | |||
| + | * '''European Parliament''' | ||
| + | |||
| + | [[Giuseppe Nisticò]] | ||
| + | [[Björn Lemmer]] | ||
| + | |||
| + | * '''European Commission''' | ||
| + | |||
| + | [[Heinz Zourek]] | ||
| + | [[Isabel de la Mata]] | ||
| + | |||
| + | * '''Austria''' | ||
| + | |||
| + | [[Marcus Muellner]] | ||
| + | |||
| + | * '''Belgium''' | ||
| + | |||
| + | [[Xavier De Cuyper]] | ||
| + | |||
| + | * '''Bulgaria''' | ||
| + | |||
| + | [[Emil Ivanov Hristov]] | ||
| + | |||
| + | * '''Cyprus''' | ||
| + | |||
| + | [[Panayiota Kokkinou]] | ||
==Funding== | ==Funding== | ||
Latest revision as of 00:22, 12 March 2009
Contents
Background
The European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
Biographical Information
History
Current activities
Views
Affiliations
People
Management Board (MB)
According to the EMEA's website, the MB is an integral governance body of the European Medicines Agency (EMEA). The Board has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance.
Individual members of the Management Board are appointed on the basis of their relevant expertise in management and, if appropriate, experience in the field of medicinal products for human or veterinary use, in such a way as to guarantee the highest levels of specialist qualifications, a broad spectrum of relevant expertise, and the broadest possible geographical spread within the European Union.
The Management Board has 35 members:
- 1 representative of each of the 27 Member States
- 2 representatives of the European Commission
- 2 representatives of the European Parliament
- 2 representatives of patients’ organisations
- 1 representative of doctors’ organisations
- 1 representative of veterinarians’ organisations
In 2009, the MB consists of:
- Chair
- European Parliament
- European Commission
Heinz Zourek Isabel de la Mata
- Austria
- Belgium
- Bulgaria
- Cyprus
Funding
Clients
Contact
Address
7 Westferry Circus; Canary Wharf; London; E14 4HB; United Kingdom
Phone
+44 2074188400
info@emea.europa.eu
Website
